Quantitative P16 and ESR1 Methylation in the Peripheral Blood of Patients With Non-Small Cell Lung Cancer

Oncology Reports - Greece
doi 10.3892/or_00000121
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Spandidos Publications

Related search

P3.03-08 Analysis of ESR1 Mutation Spectrum From Non-Small-Cell Lung Cancer in Chinese Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Detection and Significance of TregFoxP3+ and Th17 Cells in Peripheral Blood of Non-Small Cell Lung Cancer Patients

Archives of Medical Science
Medicine
2014English

Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-Small Cell Lung Cancer

Frontiers in Immunology
AllergyImmunology
2020English

Gene Expression Profiles in Peripheral Blood Mononuclear Cells Can Distinguish Patients With Non-Small Cell Lung Cancer From Patients With Nonmalignant Lung Disease

Cancer Research
Cancer ResearchOncology
2009English

Peripheral Immune Cell Gene Expression Predicts Survival of Patients With Non-Small Cell Lung Cancer

PLoS ONE
Multidisciplinary
2012English

Meta-Analyses of Gene Methylation and Smoking Behavior in Non-Small Cell Lung Cancer Patients

Scientific Reports
Multidisciplinary
2015English

CDK4/6 Inhibition Stabilizes Disease in Patients With P16-Null Non-Small Cell Lung Cancer and Is Synergistic With mTOR Inhibition

Oncotarget
Oncology
2018English

DNA Methylation in Tumor and Matched Normal Tissues From Non-Small Cell Lung Cancer Patients

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2008English

Ifosfamide in Patients With Recurrent Non Small Cell Lung Cancer

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
1986English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy